The efficacy of infliximab for patients with rheumatoid arthritis in Japan: Results of 5000 cases by post-marketing surveillance data

APLAR Journal of Rheumatology

Volumn 9, Issue 2, 2006, Pages 142-145

  Oka, Hiroshi ^a   Nishioka, Kusuki ^a   Togo, Masanori ^a   Ochi, Takahiro ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Infliximab; Multicentre study; Pneumonia; Postmarketing surveillance; Rheumatoid arthritis

Indexed keywords

ACTARIT; BUCILLAMINE; C REACTIVE PROTEIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; INFLIXIMAB; METHOTREXATE; MIZORIBINE; PENICILLAMINE; SALAZOSULFAPYRIDINE; STEROID;

ADOLESCENT; ADULT; AGED; ANAPHYLAXIS; ARTHROPATHY; ARTICLE; BACTERIAL PNEUMONIA; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; HYPOTENSION; INDUCED HYPOTHERMIA; INJECTION SITE REACTION; INTERSTITIAL PNEUMONIA; JAPAN; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; PNEUMOCYSTIS PNEUMONIA; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TUBERCULOSIS;

EID: 33745939306     PISSN: 02190494     EISSN: 14798077     Source Type: Journal    
DOI: 10.1111/j.1479-8077.2006.00198.x     Document Type: Article

References (12)

1. Choy E, Panayi G (2001) Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 344, 907-16.
2. Maini RN, Breedveld FC, Kalden JR, et al. (1998 September) Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum 41, 1552-63.
3. Lipsky PE, van der Heijde DM, St Clair EW, et al. (2000) Infliximab and methotrexate in the treatment of rheumatoid arthritis, Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med 343, 1594-602.
4. Wong JB, Singh G, Kavanaugh A (2002) Estimating the cost-effectiveness of 54 weeks of infliximab for rheumatoid arthritis. Am J Med 113, 400-8.
5. Maini RN, Breedveld FC, Kalden JR, et al. (2004) Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate. Arthritis Rheum 50, 1051-65.
6. St Clair EW, van der Heijde DM, Smolen JS, et al. (2004) Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: A randomized, controlled trial. Arthritis Rheum 50, 3432-43.
7. Miyasaka N, Takeuchi T, Eguchi K (2005) Official Japanese guidelines for the use of infliximab for rheumatoid arthritis. Mod Rheumatol 15, 4-8.
8. Wolfe F, Michaud K, Anderson J, Urbansky K (2004) Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy. Arthritis Rheum 50, 372-9.
9. Keane J, Gerson S, Braum MM (2002) Tuberculosis and treatment with infliximab. N Engl J Medical 346, 625-626.
10. Keane J (2004) Tumor necrosis factor blockers and reactivation of latent tuberculosis. Clin Infect Dis 39, 300-302.
11. Giles J, Bathon J (2004) Serious infections associated with anticytokine therapies in the rheumatic diseases. J Intensive Care Med 19, 320-34.
12. Crum NF, Lederman ER, Mark RW (2005) Infections associated with tumor necrosis factor-α antagonist. Medicine 84, 291-302.